Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, trading can resume for TNGNQ. All SEC Suspensions are for exactly 10 market days and no longer.
is it the Ban lifted, there are transactions happening today!!
TNGNQ SEC Suspension because of questions regarding the adequacy and accuracy of information about the company.
https://www.sec.gov/litigation/suspensions/2021/34-91170.pdf
Order:
https://www.sec.gov/litigation/suspensions/2021/34-91170-o.pdf
Who dumped 1,125,000 shares at 0.0002? Why? I bet it must be because of the current Giant AS size --- 10B or 10,000,000,000 shares!
Will it further crash to its All-Time-Low 0.0001 due to the planned Huge R/S? The current price 0.0006 is 500%-Higher than its Bottom 0.0001!
TNGNQ had approximately $31.6 million of principal and accrued but unpaid interest remains outstanding under the promissory notes governed by such agreements! Will the company dilute 10B shares at $0.0001 to raise $1M cash to pay off its partial Giant debts?
Anyway TNGNQ has Giant Negative Book Value --- -$2.0719 per share v.s. its peer LIQDQ has Giant Positive BV --- $0.1864 per share. TNGNQ has 10B shares Giant AS v.s. LIQDQ only has 200M or 0.2B shares Tiny AS!
The CH7-"Q" stock TNGNQ (40M shares Tiny OS) is trading at $100K MV now v.s. its Bio-Tech peer RCPIQ (171M shares Large OS) is trading at joke low $68K MV currently and another CH7 peer TXCCQ (46M shares Tiny OS) is trading at ridiculous low $55K MV!
The MV of TNGNQ at its 52-week-high 0.0030 (vs at 0.0025 now) = the MV of TXCCQ at 0.0022 (vs at mere 0.0012 now) = the MV of RCPIQ at 0.0007 (vs at mere 0.0004 now)!
Let's buy Dirt Cheap peers TXCCQ and RCPIQ since TNGNQ is 1.82 Times more expensive than TXCCQ and 1.47 Times more expensive than RCPIQ...
Yes, TNGNQ just needs some strong Slapping actions at the dirt cheap asks 0.0018 ~ 0.0048! This diamond-in-rough can easily hit Multiple Pennies again based on its current joke low Market Value ($76K) and Super Tiny FIXED SS!
At its recent high $0.021 the Market Value of TNGNQ is meager $0.845M or $845K v.s. its peer CERPQ ever hit $2.262M Market Value most recently! Which means 30-Bagger Huge rally from here for TNGNQ!
0.0015 x 0.0019 now. Today's high is 0.0023 so far! TNGNQ is on Big Fire with large trading volume! It should be very easy to hit its recent high 0.021 again based on Super Tiny float and Hyper Thin asks of Level2...
To match the same MV with its peer CERPQ, TNGNQ will create a New high 0.0562 v.s. at mere 0.0019 now!
TNGNQ 100k at .0012 waiting to be grabbed then .0018 is up.. easy money here.
TNGN has had a Q for years now. Shouldn't even be around yet let alone be trading.
I'd have to see $1 anyway to start to undo RS damage. Oh well -- obviously whatever's happening here is manufactured and not anything company related.
Maybe is or will HYPE start on "Q" SHARE? Which often run above 1000% per day
, maybe -
I do not know but I am watching more and more "Q" shares are being pumped and pushed ....
maybe also here soon
Weeeeeee
imo
I hope run coming here soon
I wonder if someone knows something?
TNGNQ Security Details
Share Structure
Market Value1 $69,578 a/o Nov 08, 2016
Authorized Shares Not Available
Outstanding Shares 36,620,124 a/o Nov 10, 2014
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
did not realize SS was so low on this one.
Another Q Blast!!! Somebody slap $340 on that ask and let this baby fly!!!!
Gotta look, but why the spike? Thought this thing was bankrupt.
WOW - TODAY '4 or more - WEEEEEE
The hell did I miss here????? Blast from the past in my portfolio just shot up! And ask is about double now.....????
TNGN bankruptcy. New symbol TNGNQ:
http://otce.finra.org/DailyList
There is some running going on here....
As part of the Termination Plan (as defined and described below), the Company plans to terminate the employment of Mr. Miclot, Mr. Davis and Dr. Bertram effective December 5, 2014, December 23, 2014 and December 5, 2014, respectively.
On December 1, 2014, the Company’s Board of Directors (the “Board”) approved a plan of termination (the “Termination Plan”) that will result in a workforce reduction of all of the Company’s 29 employees (the “Terminated Employees”), including Mr. Miclot, Mr. Davis and Dr. Bertram, by the end of 2014. The Terminated Employees serve in research, development, financial and administrative roles.
This one has been bouncing around some pretty large percentages as of late.
An Organ Regeneration Platform for
Industrial Production of Hollow Neo-Organs
Published: November 26, 2014
Tengion’s organ regeneration platform
Lol, I have been holding way too long! Just hoping to eventually not lose my ass.
More like amusing if you're a 2 plus year long term holder:)
Yes, a huge sell off! It's been going on for a while....
If this goes up like it went down, it'll be the stock of the century..
Hopefully better than the share price!
Reverse split, increase the A/S and bend the shareholders without any lube!!
Wow! TNGN, AS increased to 10 Billion shares !!!
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9812605
Vast dilitions!!!!!!!
What's your definition of mega run?
TNGN~~in little REVERSAL coming,Oversold http://stockcharts.com/freecharts/gallery.html?s=tngn
TNGN~~"We believe this decision increases our ability to realize the value of our Organ Regeneration Platform and we remain committed to maximizing value for our stakeholders," commented John L. Miclot, President and Chief Executive Officer of Tengion.
TNGN~~Tengion Retains Jefferies to Explore Strategic Options for the Company
WINSTON-SALEM, N.C., Sept. 22, 2014 (GLOBE NEWSWIRE) -- Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today announced that the Company, with the support of its Board of Directors, is exploring all strategic options to maximize the value of its assets and has retained Jefferies LLC as exclusive financial advisor to assist it with reviewing and structuring potential strategic transactions.
"We believe this decision increases our ability to realize the value of our Organ Regeneration Platform and we remain committed to maximizing value for our stakeholders," commented John L. Miclot, President and Chief Executive Officer of Tengion.
The Company does not intend to comment further on this process unless and until a definitive agreement has been reached.
About Tengion
Tengion, a clinical-stage regenerative medicine company, is focused on developing its Organ Regeneration Platform™ to harness the intrinsic regenerative pathways of the body to regenerate a range of native-like organs and tissues with the goal of delaying or eliminating the need for chronic disease therapies, organ transplantation, and the administration of anti-rejection medications. The Company is currently conducting Phase 1 clinical trials in Sweden and the United States for its Neo-Kidney Augment, which is intended to prevent or delay dialysis and transplantation by increasing renal function in patients with advanced chronic kidney disease. A Phase 1 trial for the Company's Neo-Urinary Conduit, an autologous implant that is intended to catalyze regeneration of native-like urinary tissue for bladder cancer patients requiring a urinary diversion following bladder removal, has completed enrollment.
TNGN is coming a mega run here
Wow - what a drop. Every couple days I check this and think NOW is the time to buy. Now I just don't know.
This looks like a decent potential trade
Followers
|
32
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
594
|
Created
|
01/19/11
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |